← FDA Drug Approvals (Drugs@FDA)
PEMETREXED DISODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2022-08-04
Drug application
- FDA Application #
ANDA210047- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PEMETREXED DISODIUM
- Generic name
- Pemetrexed Disodium
- Active ingredients
- PEMETREXED DISODIUM
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- AMNEAL
- First approval
- 2022-08-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown